168 related articles for article (PubMed ID: 2502790)
21. Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats.
McMillen BA; Walter S; Williams HL; Myers RD
Alcohol; 1994; 11(3):203-6. PubMed ID: 8060520
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms involved in the prolactin-releasing effect of benserazide.
Parati EA; Penalva A; Bondiolotti GP; Parenti M; Locatelli V; Picotti GB; Cocchi D; Müller EE
Eur J Pharmacol; 1984 Jun; 101(3-4):215-21. PubMed ID: 6468496
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan in alcoholism treatment II: inhibition of the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevation of blood acetaldehyde concentration and induction of aversion to alcohol by combined administration of tryptophan and benserazide.
Badawy AA; Bano S; Steptoe A
Alcohol Alcohol; 2011; 46(6):661-71. PubMed ID: 21896551
[TBL] [Abstract][Full Text] [Related]
24. Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.
Privette TH; Hornsby RL; Myers RD
Alcohol; 1988; 5(2):147-52. PubMed ID: 3395461
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
26. The ethanol metabolite acetaldehyde induces water and salt intake via two distinct pathways in the central nervous system of rats.
Ujihara I; Hitomi S; Ono K; Kakinoki Y; Hashimoto H; Ueta Y; Inenaga K
Neuropharmacology; 2015 Dec; 99():589-99. PubMed ID: 26298003
[TBL] [Abstract][Full Text] [Related]
27. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
Bocknik SE; Kulkarni AS
Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
[No Abstract] [Full Text] [Related]
28. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
Bakke OM; Scheline RR
J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
[No Abstract] [Full Text] [Related]
29. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
Ho AK; Smith JA
Biochem Pharmacol; 1982 Jul; 31(13):2251-5. PubMed ID: 6889864
[TBL] [Abstract][Full Text] [Related]
30. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
Polleri A; Masturzo P; Murialdo G; Carolei A
Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
[TBL] [Abstract][Full Text] [Related]
31. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
[TBL] [Abstract][Full Text] [Related]
32. Satietin: route of injection, dose response, effect on food and water intake and on running-wheel activity in the rat.
Mendel VE; Bellinger LL; Williams FE; Iredale RA
Pharmacol Biochem Behav; 1986 Feb; 24(2):247-51. PubMed ID: 3952114
[TBL] [Abstract][Full Text] [Related]
33. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.
Myers RD; Borg S; Mossberg R
Alcohol; 1986; 3(6):383-8. PubMed ID: 3814350
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
Goodale DB; Moore KE
Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
[No Abstract] [Full Text] [Related]
35. Endogenous acetaldehyde in rats. Effects of exogenous ethanol, pyrazole, cyanamide and disulfiram.
Eriksson CJ
Biochem Pharmacol; 1985 Nov; 34(22):3979-82. PubMed ID: 4062972
[TBL] [Abstract][Full Text] [Related]
36. Increased alcohol intake in low alcohol drinking rats after chronic infusion of the beta-carboline harman into the hippocampus.
Adell A; Myers RD
Pharmacol Biochem Behav; 1994 Dec; 49(4):949-53. PubMed ID: 7886112
[TBL] [Abstract][Full Text] [Related]
37. Histamine in brain may have no role for histaminergic control of food-related drinking in the rat.
Kraly FS; Arias RL
Physiol Behav; 1990 Jan; 47(1):5-9. PubMed ID: 2326344
[TBL] [Abstract][Full Text] [Related]
38. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
Myers RD; Lankford MF
Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
[TBL] [Abstract][Full Text] [Related]
39. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
Tyce GM
J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
[No Abstract] [Full Text] [Related]
40. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
Lankford MF; Björk AK; Myers RD
Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
